Can a single infusion lock in bone gains after osteoporosis treatment?
Disease control
Ongoing
This trial investigates whether a single or repeat infusion of zoledronate, or daily oral alendronate, can maintain the bone density improvements achieved with denosumab in postmenopausal women with osteoporosis. Participants who have been on denosumab for at least three years wi…
Sponsor: 424 General Military Hospital • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC